pasireotide  - Drug Details
📊 Estimates pasireotide  Dialyzability By Different_Modalities

pasireotide 

Complete Drug Information

Drug Name
pasireotide 
Trade Names
Signifor, Signifor LAR
Pregnancy Category
AU: B3
Routes of Administration
Subcutaneous injection, intramuscular injection
Formula
C58H66N10O9
Molar Mass
1047.227
Volume of Distribution
100 L/kg

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.